+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Expired

Brain Tumour Research Grants

Brain Tumour Foundation of Canada

Brain Tumour Foundation of Canada is a national, not-for-profit organization committed to reaching everyCanadian affected by abrain tumour through support, education, information andresearch.

We are inviting applications for high-quality brain tumour research focused on Low Grade Gliomas or other rare brain tumours. Priority will be given to projects with hypotheses that evaluate risk factors, or address access to care or issues of quality of life or patient outcomes.

Applications are welcome from individual investigators or multidisciplinary teams (submitted by a lead investigator). Innovative proposals from early career investigators with original concepts or collaborative approaches are strongly encouraged.

Research approaches may include clinical studies, laboratory-based studies, or population/public health studies.

Basic Research: In this context, ‘Basic’ research involves the development of new concepts (e.g., signaling pathways using an in vitro model). Basic science research aims to expand our scientific knowledge base, with the goal of improving our understanding of the cause and progression of brain tumours.

Clinical Research: Clinical research involves studying people, their data or tissue samples to improve how we detect, diagnose, treat, and prevent disease. This includes evaluating new treatments, interventions that alleviate symptoms and/or improve quality of life and natural history studies which track how diseases develop and progress over time.

Population or Public Health Research: A population study examines a group of individuals from the general population who share a common characteristic, such as age, gender, or health condition. These studies explore demographic, environmental, or other risk factors influencing the occurrence, progression, prognosis, or survival with a disease.

Translational Research: In this context, ‘Translational’ is defined as pre-clinical research evaluating the therapeutic potential of recent discoveries in the basic mechanisms of either brain tumour pathogenesis or experimental therapeutics. Human studies are excluded

GRANT AMOUNT Applications will be considered for funding of up to $25,000.

DURATION OF FUNDING Funding is intended for projects that can be reasonably completed within two years. Funds will be released upon receipt of all required documentation, including proof of ethics approval. A financial statement is required with each project report. Any unspent funds must be returned to Brain Tumour Foundation of Canada at project completion.

SELECTION CRITERIA

Applications will be evaluated based on the following criteria: 1.Qualifications of applicant 2.Quality and feasibility of the research proposal 3.Capacity of the host institution or laboratory to carry out the project 4.Potential impact on the lives of brain tumour patients, caregivers, and healthcare professionals 5.Inclusion of junior investigators, patient partners, or other collaborative participants

AI Based Application Success Predictor

What BTFC Funds & Program Features

From the publicly available info, BTFC offers several funding mechanisms:

Research Grants (up to CAD $25,000) for Canadian researchers. These support work in basic, translational, clinical, epidemiological, quality of life, or outcomes research.

Fellowships: bi-annual awards covering salary & lab expenses for two years (≈ $50,000/year) to foster young investigators moving into brain tumour research.

Elevation Grants: larger grants (for example ~CAD $50,000) for glioblastoma or other high-need tumour research.

Professional Development Grants (for Health Care Professionals): smaller grants to enable HCPs (nurses, therapists, etc.) to attend conferences/workshops or otherwise enhance skills relevant to neuro-oncology.

BTFC also publishes lists of its past grant/fellowship recipients, showing diverse projects (basic, translational, patient-oriented, pediatric, glioblastoma, quality of life, etc.).

Predictors of Success (What Past Recipients / BTFC Guidelines Suggest)

Based on the call guidelines, past recipients and project types, there are multiple traits or features that seem to correlate with successful BTFC applications or outcomes. These aren’t formally quantified in public papers (at least not yet), but we can infer them:

Predictor	What It Looks Like / How It Helps
Early-career status / emerging investigators	Fellowships and many Research Grants are designed to help younger scientists build independence. Having less prior funding can sometimes be an advantage if you can show promise.
Novel / Innovative Ideas	Projects that propose original or novel hypotheses, or apply new technologies or methods, especially in difficult tumour types (glioblastoma, rare brain tumours). “Innovative proposals … original concepts …” is explicitly mentioned in BTFC’s grant calls.
Clinical or Patient-Oriented / Translational Impact	BTFC seems to value work that will directly impact patients’ lives: quality of life, outcomes, access to care, therapeutic advances, etc. E.g., epidemiological studies, health services research, patient‐oriented work are explicitly eligible.
Feasibility within Budget & Duration	Projects small enough to be done with the provided resources (e.g. $25K grants, or two-year fellowships). Having a clear plan, preliminary data, or evidence of infrastructure helps.
Multidisciplinary / Collaborative Teams	Some calls encourage collaboration. Projects involving more than one domain (basic + clinical, or epidemiology + lab work) seem to have been funded. This may improve strength of impact or innovation.
Focus on High-Need Tumour Types & Understudied Areas	Glioblastoma, rare brain tumours, pediatric tumours, issues of survivorship, access to care / quality of life are often spotlighted. If your work addresses a gap, you may have an edge.
Professional Development & Capacity Building	For HCP roles or early career scientists, grants that include training, mentorship, or skill building are valued — BTFC has dedicated schemes for that.
Dissemination / Knowledge Mobilization	Presenting findings, publishing, sharing with clinical and patient audiences seem to matter. BTFC’s recipients nearly always aim to move toward real impact.

What Makes a Strong BTFC Application

Putting together the above, here are features you’d want to ensure your application has to align with what tends to succeed with BTFC:

Clear & Strong Research Question / Hypothesis
It should be linked to the biology, treatment, or quality of life in brain tumour disease; especially if it is something not well explored (glioblastoma, rare, pediatric, survivorship, etc.).

Evidence of Feasibility
This could be preliminary data, prior work in the lab, existing resources (patient cohort, lab space, collaborators, etc.), realistic methodology, and timeline.

Appropriate Scale / Budget
For the smaller grants (≈$25K), ensure your aims are achievable with the fund—and avoid overreach. For Fellowships, ensure time and resources are well allocated.

Demonstrated Impact or Path to Impact
Be explicit: Will this lead to better treatments? Better patient quality of life? Did you consider access issues? Outcomes? Plan for translating findings.

Early Career / Developer Profile
If you are early career, make that clear. Emphasize how this funding will help you move toward independence or expand your capacity. Mention mentorship if you have strong support.

Novelty / Innovation
Especially in under-studied tumour types, or with new technologies or creative study designs.

Collaboration & Multidisciplinarity
Having co-investigators in other relevant fields (clinical, lab, epidemiology, imaging, etc.) can strengthen the application.

Clear Dissemination Plan
How you’ll publish, present, and make findings accessible—this shows you are anticipating impact and not just running experiments.

Align with BTFC Priority Areas
Check the current call: BTFC sometimes prioritizes certain tumour types (e.g. low grade gliomas, rare tumours), certain themes (access to care, quality of life, outcomes). Align your project accordingly.

Specialties

Cancer

Neurosciences

Public Health

Clinical Trials

Oncology

Eligibility Requirements

Funding is available for projects conducted within Canada. Applicants from across the country are encouraged to apply.

Eligible Countries:

Canada

Sponsor Details

Sponsor Institute/Organizations: Brain Tumour Foundation of Canada

Sponsor Type: Corporate/Non-Profit

Address: 205 Horton St E, Suite 203, London, ON N6B 1K7

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity